Insomnia-anxiety comorbidity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients diagnosed with gynecological tumors (ovarian cancer, cervical cancer, endometrial cancer, vulvar malignancy, vaginal malignancy, uterine sarcoma, gestational trophoblastic tumor, etc.) requiring chemotherapy, insomnia and anxiety according to pathology; (2) Aged between 20 and 70 years old (including 20 and 70 years old); (3) Subject agrees and signs informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients who had received sleep-related medication within 2 weeks before entering the study; (2) Patients with serious primary diseases of the heart, kidney, brain, spleen and other viscera and mental patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pittsburgh sleep quality inde,PSQI ; Athens Insomnia Scale,AIS;;Hamilton Anxiety Rating Scale,HAMA; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep monitoring bracelet (heart rate, deep sleep time, light sleep time, REM time); | — |
Countries
China
Contacts
Obstetrics & Gynecology Hospital of Fudan University